haus6 Antibody

What is HAUS6 and what is its primary function in cellular biology?

HAUS6 is one of eight subunits comprising the 390-kD human augmin complex (HAUS complex). The augmin complex was initially identified in Drosophila, with its name derived from the Latin verb 'augmentare,' meaning 'to increase.' HAUS6 functions as a microtubule-binding protein that plays a vital role in microtubule generation within the mitotic spindle during cell division. This protein is essential for proper mitotic spindle assembly and accurate chromosome segregation during mitosis . The molecular weight of HAUS6 is approximately 109 kDa, and it contains specific structural domains that facilitate its interaction with other components of the augmin complex and with microtubules .

How does HAUS6 dysfunction contribute to disease pathology?

Dysregulation of HAUS6 function has been directly linked to defects in cell proliferation and mitotic errors. These cellular abnormalities can significantly contribute to the development of various diseases, particularly cancer . When HAUS6 function is compromised, the mitotic spindle fails to assemble correctly, leading to chromosome segregation errors, genomic instability, and potentially oncogenic transformations. Research into HAUS6 dysfunction provides valuable insights into the mechanisms underlying cell division defects and may identify potential targets for therapeutic interventions in cancer treatment. Investigating the expression and function of HAUS6 in patient samples can help establish its potential role as a biomarker or therapeutic target in specific cancer types.

What are the current known interaction partners of HAUS6 in the augmin complex?

HAUS6 interacts with the seven other subunits of the augmin complex (HAUS1-5, HAUS7-8) to form a functional unit essential for microtubule nucleation from existing microtubules during mitosis. Beyond its interactions within the augmin complex, HAUS6 also associates with γ-tubulin ring complex (γ-TuRC) components, which are critical for centrosome-independent microtubule nucleation within the mitotic spindle. These interactions create a molecular bridge between existing microtubules and newly nucleated microtubules, facilitating the amplification of microtubule density during spindle assembly. Understanding these protein-protein interactions provides insights into the molecular mechanisms underlying mitotic spindle organization and could reveal potential targets for modulating cell division in research or therapeutic contexts.

What criteria should researchers consider when selecting a HAUS6 antibody for specific experimental applications?

When selecting a HAUS6 antibody, researchers should evaluate several critical factors to ensure optimal experimental outcomes:

• Application compatibility: Verify the antibody has been validated for your specific application (WB, IHC-P, ICC/IF, ELISA) . For example, GeneTex's GTX118732 and VWR's anti-HAUS6 antibody have been validated for Western blotting, immunohistochemistry, and immunofluorescence applications .

• Epitope specificity: Consider the immunogen used to generate the antibody. Many commercial HAUS6 antibodies utilize recombinant proteins encompassing specific regions of the human HAUS6 protein . For instance, Assay Genie's CAB4797 antibody was generated using a recombinant fusion protein corresponding to amino acids 676-955 of human HAUS6 (NP_060115.3) .

• Species reactivity: Confirm the antibody recognizes HAUS6 in your species of interest. Most available antibodies are reactive with human HAUS6, with some showing cross-reactivity with mouse HAUS6 .

• Validation evidence: Examine published literature and supplier validation data demonstrating the antibody's specificity and performance in various applications.

• Clonality: Consider whether a polyclonal or monoclonal antibody better suits your research needs. Currently, most commercial HAUS6 antibodies are rabbit polyclonals .

What validation experiments should be performed to confirm HAUS6 antibody specificity?

To ensure antibody specificity and reliability, researchers should implement a comprehensive validation strategy:

• Positive and negative controls: Use cell lines or tissues with known HAUS6 expression patterns. For negative controls, HAUS6 knockdown/knockout samples or pre-immune serum can be employed.

• Western blot analysis: Verify the antibody detects a single band of the expected molecular weight (~109 kDa) . Multiple bands might indicate non-specific binding or protein degradation.

• Immunoprecipitation followed by mass spectrometry: This approach can confirm that the antibody specifically precipitates HAUS6 rather than other proteins.

• Peptide competition assay: Pre-incubation of the antibody with its specific immunogenic peptide should abolish or significantly reduce signal detection.

• Orthogonal validation: Compare results using antibodies targeting different epitopes of HAUS6 or alternative detection methods such as RNA expression analysis.

• Cell cycle-dependent localization: Since HAUS6 has a specific localization pattern during mitosis, immunofluorescence studies showing the expected spindle localization during mitosis provide functional validation.

How can researchers distinguish between non-specific binding and true HAUS6 signal in their experiments?

Distinguishing specific HAUS6 signal from non-specific binding requires several methodological approaches:

• Control experiments: Include isotype controls, secondary-only controls, and pre-immune serum controls to identify background signal levels.

• HAUS6 depletion: Use siRNA or CRISPR/Cas9 to deplete HAUS6 and confirm signal reduction in your experimental system.

• Cell cycle synchronization: Since HAUS6 expression and localization changes throughout the cell cycle, synchronizing cells at different cell cycle stages and observing the expected patterns can confirm signal specificity.

• Subcellular fractionation: HAUS6 should be enriched in specific cellular fractions associated with the mitotic spindle during cell division.

• Co-localization studies: Perform dual immunofluorescence with antibodies against known HAUS6 interactors or other augmin complex components to confirm the expected co-localization patterns.

• Peptide blocking: Pre-incubation of the antibody with the immunizing peptide should eliminate specific staining while leaving non-specific background unchanged.

What are the optimal protocols for using HAUS6 antibodies in Western blotting applications?

For optimal Western blotting results with HAUS6 antibodies, researchers should follow these methodological guidelines:

• Sample preparation: Due to HAUS6's role in mitotic spindle assembly, consider using synchronized cell populations or tissues with high mitotic indices. Extract proteins using buffers containing protease inhibitors to prevent degradation.

• Protein loading: Load 20-50 μg of total protein per lane for cell lysates. For tissue samples, optimization may be required.

• Gel selection: Use 8-10% SDS-PAGE gels to achieve good resolution around the 109 kDa molecular weight of HAUS6 .

• Transfer conditions: For efficient transfer of this higher molecular weight protein, use a wet transfer system with methanol-free transfer buffer at 30V overnight at 4°C.

• Blocking: Block membranes in 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.

• Primary antibody incubation: Dilute antibodies according to manufacturer recommendations, typically between 1:500-1:3000 in blocking buffer, and incubate overnight at 4°C.

• Detection: Use appropriate HRP-conjugated secondary antibodies and enhanced chemiluminescence detection systems.

• Controls: Include positive control lysates from cells known to express HAUS6 and, when possible, HAUS6-depleted samples as negative controls.

What are the recommended procedures for immunofluorescence studies of HAUS6 during mitosis?

For optimal visualization of HAUS6 during mitosis using immunofluorescence:

• Cell preparation: Grow cells on coated coverslips to approximately 70% confluency. For enriching mitotic cells, consider treatment with nocodazole (100 ng/ml for 4-6 hours) followed by release.

• Fixation method: Use 4% paraformaldehyde for 15 minutes at room temperature, followed by permeabilization with 0.2% Triton X-100 in PBS for 5 minutes. Alternative fixation methods like methanol fixation (-20°C for 10 minutes) may better preserve microtubule structures.

• Blocking: Block with 5% normal serum (from the species of the secondary antibody) in PBS containing 0.1% Triton X-100 for 30-60 minutes.

• Primary antibody: Dilute HAUS6 antibodies at 1:100-1:1000 in blocking solution and incubate overnight at 4°C.

• Co-staining recommendations: For comprehensive visualization of mitotic structures, co-stain with antibodies against α-tubulin (microtubules), γ-tubulin (centrosomes), and DAPI (DNA).

• Image acquisition: Use confocal microscopy for high-resolution imaging of HAUS6 localization at the mitotic spindle. Z-stack acquisition is recommended to capture the three-dimensional organization.

• Analysis: Quantify the fluorescence intensity of HAUS6 at the spindle relative to the cytoplasmic background. Compare localization patterns across different mitotic stages.

How should researchers approach HAUS6 detection in immunohistochemistry of tissue samples?

For successful immunohistochemical detection of HAUS6 in tissue samples:

• Tissue preparation: Use freshly fixed tissue sections (4% paraformaldehyde or formalin-fixed paraffin-embedded) at 4-6 μm thickness.

• Antigen retrieval: Perform heat-induced epitope retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) for 20 minutes. Optimize the retrieval method as it is critical for antibody accessibility.

• Endogenous peroxide blocking: Block endogenous peroxidase activity using 3% hydrogen peroxide in methanol for 10 minutes.

• Protein blocking: Block non-specific binding with 5-10% normal serum from the secondary antibody species for 30-60 minutes.

• Primary antibody: Dilute HAUS6 antibodies at 1:100-1:1000 and incubate overnight at 4°C in a humidified chamber.

• Detection system: Use a polymer-based detection system conjugated with HRP for enhanced sensitivity and reduced background.

• Counterstaining: Counterstain nuclei with hematoxylin to provide context for HAUS6 expression patterns.

• Controls: Include positive control tissues with known HAUS6 expression. For negative controls, omit primary antibody or use pre-immune serum.

• Scoring system: Develop a standardized scoring system based on staining intensity and percentage of positive cells, particularly focusing on mitotic cells.

What are common challenges when working with HAUS6 antibodies and how can they be addressed?

Researchers frequently encounter several challenges when working with HAUS6 antibodies:

• Low signal strength: This may result from low HAUS6 expression in asynchronous cell populations.

  • Solution: Enrich for mitotic cells using synchronization methods or mitotic shake-off to increase the proportion of cells expressing HAUS6 at detectable levels.

• High background: Non-specific binding can obscure true HAUS6 signal.

  • Solution: Optimize blocking conditions by testing different blockers (BSA, normal serum, casein) and concentrations. Increase washing steps and duration. Use affinity-purified antibodies when available.

• Inconsistent results between experiments:

  • Solution: Standardize protocols, particularly fixation methods and antibody incubation times. Use the same lot of antibody when possible or validate new lots against previous results.

• Discrepancies between different detection methods:

  • Solution: Each application requires specific optimization. Validate the antibody for each application independently and optimize buffer compositions, incubation times, and detection methods.

• Inability to detect endogenous HAUS6 in certain cell types:

  • Solution: Confirm HAUS6 expression at the mRNA level first. Some cell types may express HAUS6 at levels below the detection limit of standard protocols, requiring signal amplification methods.

How can cell cycle variations in HAUS6 expression affect experimental outcomes?

HAUS6 expression and localization patterns vary significantly throughout the cell cycle, which can profoundly impact experimental results:

• Expression level variations: HAUS6 expression may increase during G2/M phases of the cell cycle, making detection more challenging in predominantly interphase cell populations.

  • Recommendation: Synchronize cells or enrich for mitotic populations when studying HAUS6. Consider using methods like double thymidine block followed by release, or nocodazole treatment followed by mitotic shake-off.

• Localization pattern changes: During interphase, HAUS6 may show diffuse cytoplasmic distribution, whereas during mitosis, it concentrates at the mitotic spindle.

  • Recommendation: Include cell cycle markers (e.g., phospho-histone H3 for mitotic cells) in immunofluorescence studies to correlate HAUS6 localization with specific cell cycle stages.

• Protein complex formation: HAUS6 incorporation into the augmin complex may affect epitope accessibility.

  • Recommendation: Test multiple antibodies targeting different epitopes of HAUS6. Consider native versus denaturing conditions for different applications.

• Post-translational modifications: HAUS6 may undergo cell cycle-dependent phosphorylation or other modifications.

  • Recommendation: Use phospho-specific antibodies when studying specific modifications, or implement phosphatase treatments to assess the impact of phosphorylation on antibody recognition.

What control samples are essential for validating experimental results with HAUS6 antibodies?

A comprehensive set of controls is crucial for validating HAUS6 antibody experiments:

• Positive controls:

  • Cell lines with documented HAUS6 expression (HeLa, U2OS, MCF7)

  • Tissues with high mitotic indices (embryonic or cancer tissues)

  • Recombinant HAUS6 protein for Western blot standardization

• Negative controls:

  • HAUS6 knockdown/knockout samples generated using siRNA or CRISPR/Cas9

  • Tissues known to express minimal HAUS6

  • Secondary antibody-only controls to assess non-specific binding

  • Pre-immune serum controls

• Specificity controls:

  • Peptide competition assays using the immunizing peptide

  • Multiple antibodies targeting different HAUS6 epitopes

  • Correlation with mRNA expression data

• Cell cycle controls:

  • Synchronized cell populations at different cell cycle stages

  • Co-staining with cell cycle markers (cyclin B1, phospho-histone H3)

  • Mitotic arrest/release experiments to track dynamic changes

How can HAUS6 antibodies be utilized in studying cancer progression and therapeutic responses?

HAUS6 antibodies can provide valuable insights into cancer biology through several advanced applications:

• Prognostic biomarker evaluation: Analyze HAUS6 expression levels in tumor tissue microarrays to correlate with clinical outcomes, tumor grade, and metastatic potential.

  • Methodology: Standardized immunohistochemistry protocols with quantitative scoring systems that account for both expression intensity and percentage of positive cells.

• Therapeutic response monitoring: Assess changes in HAUS6 expression or localization following treatment with anti-mitotic drugs or other cancer therapeutics.

  • Methodology: Time-course experiments with synchronized cancer cell lines treated with clinically relevant doses of therapeutics, followed by quantitative immunofluorescence or Western blot analysis.

• Resistance mechanism identification: Compare HAUS6 expression and function between drug-sensitive and drug-resistant cancer cell lines.

  • Methodology: Generate resistant cell lines through long-term drug exposure, then analyze HAUS6 expression, post-translational modifications, and protein-protein interactions using co-immunoprecipitation with HAUS6 antibodies.

• Synthetic lethality screening: Use HAUS6 antibodies to validate hits from synthetic lethality screens that identify genes whose inhibition is selectively lethal when combined with HAUS6 dysregulation.

  • Methodology: Combine HAUS6 knockdown/overexpression with candidate gene modulation, then analyze mitotic progression and cell viability.

What approaches can reveal HAUS6 interaction partners and post-translational modifications?

Advanced methodologies for studying HAUS6 protein interactions and modifications include:

• Proximity-dependent biotin identification (BioID): Fuse HAUS6 to a biotin ligase to identify proteins in close proximity during specific cell cycle stages.

  • Protocol elements: Generate stable cell lines expressing HAUS6-BioID fusion proteins, synchronize cells, induce biotinylation, perform streptavidin pulldown, and analyze by mass spectrometry.

• Immunoprecipitation-mass spectrometry (IP-MS): Use HAUS6 antibodies to pull down the protein and its interacting partners for mass spectrometric analysis.

  • Optimization considerations: Crosslinking may help preserve transient interactions. Use multiple HAUS6 antibodies targeting different epitopes to avoid biasing the interactome data due to epitope masking.

• Phospho-specific antibody development: Generate antibodies against predicted or known HAUS6 phosphorylation sites to study cell cycle-dependent phosphorylation events.

  • Validation approach: Compare phospho-antibody reactivity before and after phosphatase treatment or in cells treated with kinase inhibitors.

• FRET/FLIM analysis: Combine HAUS6 antibodies with fluorescently labeled secondary antibodies for Förster resonance energy transfer or fluorescence lifetime imaging microscopy to study protein-protein interactions in situ.

  • Technical considerations: Careful selection of fluorophore pairs and optimization of antibody labeling density to achieve reliable FRET signals.

How can researchers integrate HAUS6 antibody-based approaches with live cell imaging techniques?

Combining fixed-cell antibody-based detection with live-cell imaging provides comprehensive insights into HAUS6 dynamics:

• Correlative light and electron microscopy (CLEM): Perform live-cell imaging to capture dynamic events, then fix and immunostain the same cells for HAUS6 localization, followed by electron microscopy.

  • Methodological approach: Use gridded dishes for precise cell relocalization between imaging modalities. Optimize fixation protocols to preserve both fluorescent proteins and ultrastructure.

• Live-cell imaging followed by fixed-cell immunofluorescence:

  • Procedure: Track cells expressing fluorescently tagged markers (e.g., H2B-GFP) through mitosis, then fix at specific timepoints and immunostain for HAUS6 and other proteins of interest.

  • Analysis method: Align time-lapse sequences with immunofluorescence images to correlate dynamic events with molecular compositions.

• Optogenetic perturbation combined with immunofluorescence:

  • Experimental design: Use optogenetic tools to manipulate microtubule dynamics or augmin complex function in specific subcellular regions, then fix cells and immunostain for HAUS6 to assess redistribution.

  • Controls: Include non-illuminated regions within the same cell as internal controls for the perturbation effect.

• Super-resolution microscopy:

  • Application: Combine live-cell structured illumination microscopy (SIM) with fixed-cell stochastic optical reconstruction microscopy (STORM) using HAUS6 antibodies to bridge temporal and spatial resolution limitations.

  • Technical considerations: Optimize fixation protocols to minimize structural artifacts and preserve nanoscale organization.